CONMED CORPORATION (CNMD) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
CONMED CORPORATION (CNMD) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$455.40 MCurrent assets$675.67 MLiabilities$1.26 BAssets$2.30 BNon-current liabilities$803.52 MNon-current assets$1.62 BEquity$1.04 BGross equity(calculated)$1.14 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSInventoriesAccounts receivable, netPrepaid expenses and other current assetsCash and cash equivalentsGoodwillOther intangible assets, netOther assetsProperty, plant and equipment, netCurrent portion of long-term debtOther current liabilitiesAccounts payableAccrued compensation and benefitsLong-term debtDeferred income taxesOther long-term liabilitiesRetained earningsPaid-in capitalCommon stock, par value $0.01 per share; 100,000,000 shares authorized; 31,299,194 shares issued in 2026 and 2025, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Less: 1,312,367 and 328,097 shares of common stock in treasury, at cost, in 2026 and 2025, respectivelyAccumulated other comprehensive lossCurrent portion of long-term debtCurrent portion of long-term debt$177.20 MCurrent liabilitiesCurrent liabilities$455.40 MOther current liabilitiesOther current liabilities$106.77 MCurrent assetsCurrent assets$675.67 MLiabilitiesLiabilities$1.26 BInventoriesInventories$360.18 MAccounts payableAccounts payable$101.02 MAssetsAssets$2.30 BAccounts receivable, netAccounts receivable, net$239.77 MAccrued compensation and benefitsAccrued compensation and benefits$70.42 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$38.39 MNon-current liabilitiesNon-current liabilities$803.52 MCash and cash equivalentsCash and cash equivalents$37.33 MLong-term debtLong-term debt$657.05 MNon-current assetsNon-current assets$1.62 BEquityEquity$1.04 BDeferred income taxesDeferred income taxes$84.58 MGoodwillGoodwill$796.90 MOther long-term liabilitiesOther long-term liabilities$61.88 MGross equity (calculated)Gross equity(calculated)$1.14 BOther intangible assets, netOther intangible assets, net$564.42 MRetained earningsRetained earnings$625.67 MOther assetsOther assets$153.18 MPaid-in capitalPaid-in capital$513.46 MProperty, plant and equipment, netProperty, plant and equipment, net$110.14 MCommon stock, par value $0.01 per share; 100,000,000 shares authorized; 31,299,194 shares issued in 2026 and 2025, respectivelyCommon stock$313.00 KLess: 1,312,367 and 328,097 shares of common stock in treasury, at cost, in 2026 and 2025, respectivelyLess: 1,312,367 and 328,097 shares of common stockin treasury, at cost, in 2026 and 2025, respectively−$54.68 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$43.37 M
Chart details

CONMED CORPORATION (CNMD) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
2,300,306,000 US dollars
Current assets
675,665,000 US dollars
Non-current assets
1,624,641,000 US dollars
Liabilities
1,258,916,000 US dollars
Current liabilities
455,399,000 US dollars
Non-current liabilities
803,517,000 US dollars
Equity
1,041,390,000 US dollars
Inventories
360,179,000 US dollars
Accounts receivable, net
239,770,000 US dollars
Prepaid expenses and other current assets
38,388,000 US dollars
Cash and cash equivalents
37,328,000 US dollars
Goodwill
796,902,000 US dollars
Other intangible assets, net
564,416,000 US dollars
Other assets
153,179,000 US dollars
Property, plant and equipment, net
110,144,000 US dollars
Current portion of long-term debt
177,199,000 US dollars
Other current liabilities
106,766,000 US dollars
Accounts payable
101,017,000 US dollars
Accrued compensation and benefits
70,417,000 US dollars
Long-term debt
657,050,000 US dollars
Deferred income taxes
84,583,000 US dollars
Other long-term liabilities
61,884,000 US dollars
Retained earnings
625,665,000 US dollars
Paid-in capital
513,464,000 US dollars
Common stock, par value $0.01 per share; 100,000,000 shares authorized; 31,299,194 shares issued in 2026 and 2025, respectively
313,000 US dollars
Preferred stock, par value $.01 per share; authorized 500,000 shares; none outstanding
0 US dollars
Less: 1,312,367 and 328,097 shares of common stock in treasury, at cost, in 2026 and 2025, respectively
negative 54,680,000 US dollars
Accumulated other comprehensive loss
negative 43,372,000 US dollars
Gross equity (calculated)
1,139,442,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
CONMED CORPORATION (CNMD) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!